Mum's fight for Crohn's biologics access for sons
A Kambah mother fights for PBS reform so her sons with Crohn's can access biologics, a first-line treatment in other OECD nations, instead of 18 tablets daily. #Health #Crohns #Australia
Category : Search result: pharmaceutical packaging
Liquidators get court nod to probe Creso Pharma packagers
Liquidators have won court approval to investigate Creso Pharma's former packagers as they pursue over $20 million owed to creditors. Get the full details on the legal pursuit.
Mayne Pharma Shares Crash on Government PBS Decision
Mayne Pharma's stock plummeted 20% after the government removed key products from the PBS. Discover the full impact on investors and the pharmaceutical sector.
Australia Blocks US Takeover of SA Pharma Company
Treasurer Jim Chalmers blocks US firm's takeover of South Australian pharmaceutical company, citing national interest in healthcare security. Read the full details.
Woman needs $500k drug for rare disease CTX
Dominique Roth battles rare CTX disease but the life-changing drug costs $500,000 annually. Her story highlights urgent need for PBS reforms to help Australians with rare conditions.
Govt Funds $440k Cancer Drug, Now $32 For Patients
Broadcasting legend Sandy Roberts celebrates as a $440,000 myeloma drug is added to the PBS, costing patients under $32. A game-changer for cancer treatment in Australia.
ADHD Medication Poisonings Surge 400% in Australia
Alarming 400% increase in ADHD medication poisonings reported in Australia over past decade. Experts warn of growing prescription rates and accidental overdoses.
Supermarkets fail plastic sustainability for third year
National audit reveals no major Australian supermarket meets plastic sustainability standards. Shippers pay more to avoid plastic packaging. Discover the full investigation.
Brown Brothers' Sustainable Aluminium Prosecco for Summer
Discover how Brown Brothers' innovative aluminium-canned Prosecco is transforming sustainable wine consumption while delivering premium quality and convenience for Australian summer entertaining.
Mayne Pharma Plunges as US Deal Controversy Continues
Australian pharmaceutical giant Mayne Pharma faces investor backlash as its controversial US licensing agreement continues to dominate trading, creating clear winners and losers on the ASX.
Page 1 of 1